Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation

por Brown, Joshua D., Shewale, Anand R., Talbert, Jeffery C.
Publicado 2016

Acute treatment patterns in patients with migraine newly initiating a triptan

por Lipton, Richard B, Marcus, Steven C, Shewale, Anand R, Dodick, David W, Viswanathan, Hema N, Doshi, Jalpa A
Publicado 2020

Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response

por Marcus, Steven C, Shewale, Anand R, Silberstein, Stephen D, Lipton, Richard B, Young, William B, Viswanathan, Hema N, Doshi, Jalpa A
Publicado 2020

Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHI...

por Lipton, Richard B., Singh, Rashmi B. Halker, Revicki, Dennis A., Zhao, Sihui, Shewale, Anand R., Lateiner, Jordan E., Dodick, David W.
Publicado 2022

Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II

por Dodick, David W., Lipton, Richard B., Ailani, Jessica, Halker Singh, Rashmi B., Shewale, Anand R., Zhao, Sihui, Trugman, Joel M., Yu, Sung Yun, Viswanathan, Hema N.
Publicado 2020